Elevai Labs Common Stock logo

Elevai Labs Common StockNASDAQ: ELAB

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Next earnings report:

30 August 2024

Last dividends:

N/A

Next dividends:

N/A
$10.96 M
-84%vs. 3y high
18%vs. sector
-vs. 3y high
-vs. sector
-65%vs. 3y high
80%vs. sector
-91%vs. 3y high
61%vs. sector

Price

after hours | Mon, 01 Jul 2024 20:43:15 GMT
$0.58-$0.01(-1.69%)

Dividend

No data over the past 3 years
$614.60 K-$1.40 M

Analysts recommendations

Institutional Ownership

ELAB Latest News

Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
globenewswire.com14 June 2024 Sentiment: -

NEWPORT BEACH, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, announced the formation of a new Scientific Advisory Board to support the advancement of EL-22, a first-in-class engineered probiotic approach, to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.

Why Is Elevai Labs (ELAB) Stock Up 57% Today?
InvestorPlace01 February 2024 Sentiment: POSITIVE

Elevai Labs (NASDAQ: ELAB ) stock is rocketing higher on Thursday as the skincare development company's shares experience heavy trading this morning. That has more than 9.4 million shares of ELAB stock changing hands of this writing.

Why Is Elevai Labs (ELAB) Stock Up Today?
InvestorPlace16 January 2024 Sentiment: POSITIVE

Shares of medical aesthetics company Elevai Labs (NASDAQ: ELAB ) popped higher this morning following a key disclosure. Specifically, Elevai signed an exclusive, worldwide manufacturing and processing technology licensing agreement with INmune Bio (NASDAQ: INMB ) to manufacture stem cells.

ELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024
InvestorPlace12 December 2023 Sentiment: NEUTRAL

Elevai Labs (NASDAQ: ELAB ) just reported results for the third quarter of 2024. Elevai Labs reported earnings per share of -7.8 cents.

U.S. IPO Weekly Recap: IPO Market Sees A Little Activity In The Short Holiday Week
Seeking Alpha25 November 2023 Sentiment: POSITIVE

Skincare company Elevai Labs priced at the low end to raise $6 million at a $69 million market cap. Colombier Acquisition Corp. II upsized to raise $150 million. Several issuers are primed for post-Thanksgiving launches.

What type of business is Elevai Labs Common Stock?

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

What sector is Elevai Labs Common Stock in?

Elevai Labs Common Stock is in the Healthcare sector

What industry is Elevai Labs Common Stock in?

Elevai Labs Common Stock is in the Biotechnology industry

What country is Elevai Labs Common Stock from?

Elevai Labs Common Stock is headquartered in United States

What is Elevai Labs Common Stock website?

https://elevaiskincare.com

Is Elevai Labs Common Stock in the S&P 500?

No, Elevai Labs Common Stock is not included in the S&P 500 index

Is Elevai Labs Common Stock in the NASDAQ 100?

No, Elevai Labs Common Stock is not included in the NASDAQ 100 index

Is Elevai Labs Common Stock in the Dow Jones?

No, Elevai Labs Common Stock is not included in the Dow Jones index

When does Elevai Labs Common Stock report earnings?

The next expected earnings date for Elevai Labs Common Stock is 30 August 2024